Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 8-K Event Results of operations
  2. 4 Open-market sale Director sold 7,862 shares at $18.37 ($144,460)
  3. 4 Open-market sale Director sold 7,862 shares at $18.39 ($144,618)
  4. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.29 ($9,568)
  5. 4 Open-market sale Director sold 7,862 shares at $18.34 ($144,195)
  6. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.48 ($9,665)
  7. 4 Open-market sale Director sold 7,862 shares at $18.73 ($147,219)
  8. 4 Open-market sale CFO, SVP & Treasurer sold 3,026 shares at $18.56 ($56,176)
  9. 4 Open-market sale EVP, QA & Regulatory Affairs sold 8,444 shares at $18.87 ($159,376)
  10. 4 Open-market sale Director sold 39,312 shares at $18.59 ($730,755)
  11. 4 Open-market sale Director sold 63,624 shares at $18.18 ($1,156,952)
  12. 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 274,386 shares (to pay taxes)
  13. 4 Open-market sale Director sold 10,000 shares at an average $14.81 ($148,084)
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Other events
  17. 4 Shares withheld for taxes President and General Counsel gave up 3,394 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, Production Center gave up 146 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 146 shares (to pay taxes)
  20. 4 Grant or award Director acquired 5,844 shares (grant or award)

Page 36 of 48 · 958 filings